N@N

HPY, CAVM, EBS, EXH, MDAS, Expected to Trade Lower After Bearish Insider Trading

^{Published on 2011-06-03 06:20:54 - WOPRAI}
 

June 3, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. HEARTLAND PAYMENT SYSTEMS, INC. (NYSE:HPY), CAVIUM NETWORKS, INC. (NASDAQ:CAVM), EMERGENT BIOSOLUTIONS, INC. (NYSE:EBS), EXTERRAN HOLDINGS INC. (NYSE:EXH), MEDASSETS INCORPORATION (NASDAQ:MDAS) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     HPY        HEARTLAND PAYMENT SYSTEMS, INC.     Carr, Robert O                      CEO         64,439         98                -28.6%                 24        
     CAVM       CAVIUM NETWORKS, INC.               Chadwick, Arthur D                  CFO         16,900         99                -22.7%                 19        
     EBS        EMERGENT BIOSOLUTIONS, INC.         Abdun, Nabi Daniel J                P           178,515        87                -31.6%                 8         
     EXH        EXTERRAN HOLDINGS INC.              Childers, Douglas Bradley           O           7,000          87                -41.1%                 6         
     MDAS       MEDASSETS INCORPORATION             Rutherford, John C                  D           587,000        95                -12.0%                 9         

HEARTLAND PAYMENT SYSTEMS, INC. (NYSE:HPY) - Heartland Payment Systems, Inc. provides bankcard payment processing services to merchants in the United States and Canada. The company facilitates the exchange of information and funds between merchants and cardholders financial institutions; and provides electronic payment processing services to merchants, including merchant set-up and training, transaction authorization and electronic draft capture, clearing and settlement, merchant accounting, merchant assistance and support, and risk management. It delivers credit/debit/prepaid card processing, check management, and payments solutions. Heartland Payment Systems, Inc. Heartland Payment Systems, Inc. also offers additional services to its merchants, such as payroll processing, gift and loyalty programs, prepaid and stored-value solutions, and paper check processing, as well as sells and rents point-of-sale devices and supplies. The company principally serves small and mid-sized merchants, as well as large national merchants, primarily in the petroleum industry. As of February 18, 2010, it delivered solutions to approximately 250,000 business locations nationwide. The company was incorporated in 2000 and is headquartered in Princeton, New Jersey.

CAVIUM NETWORKS, INC. (NASDAQ:CAVM) - Cavium Networks, Inc. designs, develops, and markets semiconductor processors for intelligent and secure networks. Its semiconductor products enable customers to develop networking, wireless, storage, and electronic equipment that are application-aware and content-aware, and securely process voice, video, and data traffic at high speeds. The companys products also include a suite of embedded security protocols, which enable unified threat management, secure connectivity, network perimeter protection, deep packet inspection, network virtualization, broadband gateways, 3G/4G wireless infrastructure, storage systems, wireless HDMI cable replacement, and embedded video applications. Its products are used in networking equipment, including routers, switches, content-aware switches, UTM and other security appliances, application-aware gateways, voice/video/data or triple-play gateways, wireless local area network, and 3G/Wimax/Long Term Evolution access, aggregation and gateway devices, storage networking equipment, servers and intelligent network interface cards, Internet protocol surveillance systems, digital video recorders, wireless HDMI cable replacement systems, and video conferencing systems; and connected home and office equipment, such as print servers, wireless routers, and broadband gateways. The company sells its products directly or through contract manufacturing organizations and distributors to the providers of networking, wireless, storage, and consumer electronic equipment, as well as to original design manufacturers and contract electronics manufacturers primarily in the United States, Hong Kong, Taiwan, Japan, and China. It has a strategic collaboration agreement with Renesas Technology Corp. Cavium Networks, Inc. was founded in 2000 and is based in Mountain View, California.

EMERGENT BIOSOLUTIONS, INC. (NYSE:EBS) - Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the bodys immune system. The companys biodefense segment develops, manufactures, and commercializes drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients after they are exposed to anthrax and botulinum toxin. Emergents commercial segment develops products for use against infectious diseases. These include a single-dose typhoid vaccine in phase II clinical development; a hepatitis B vaccine in phase II clinical development, and a group B streptococcus vaccine for women of childbearing age for protection of the fetus and newborn babies, which is in phase I clinical trials. Emergent is also developing chlamydia and meningitis B vaccines. Emergent primarily works for the U.S. Defense and Health & Human Services departments. It has collaboration agreements with the British Health Protection Agency for the development of a human botulinum immune globulin candidate and with Sanofi Pasteur for the development of meningitis B vaccine candidate. The company, which was founded in 1998, is based in Rockville, Maryland.

EXTERRAN HOLDINGS INC. (NYSE:EXH) - Exterran Holdings, Inc., together with its subsidiaries, provides operations, maintenance, service, and equipment for oil and natural gas industry. The companys Contract Operations segment offers natural gas compression and production, and processing services, as well as provides engineering, procurement, and on site construction of natural gas compression stations and/or crude oil or natural gas production and processing facilities. Its Aftermarket Services segment sells parts and components, and provides operation, maintenance, overhaul, and reconfiguration services. The companys Fabrication segment designs, engineers, fabricates, installs, and sells natural gas compression units and accessories; and oil and natural gas production and processing equipment designed to heat, separate, dehydrate, and condition crude oil and natural gas. Its products include line heaters, oil and natural gas separators, glycol dehydration units, dewpoint control plants, water treatment, mechanical refrigeration and cryogenic plants, and skid-mounted production packages designed for both onshore and offshore production facilities. This segment also provide engineering, procurement, and construction services primarily related to the manufacturing of process equipment for refinery and petrochemical facilities; the construction of tank farms; and the construction of evaporators and brine heaters for desalination plants. As of December 31, 2009, Exterran Holdings provided contract operations services primarily using a fleet of 10,433 natural gas compression units with an aggregate capacity of approximately 4,321,000 horsepower in North America; and a fleet of 1,164 units with an aggregate capacity of approximately 1,234,000 horsepower internationally. The company was founded in 1990 and is based in Houston, Texas.

MEDASSETS INCORPORATION (NASDAQ:MDAS) - MedAssets, Inc. provides technology enabled products and services for hospitals, health systems, and ancillary healthcare providers in the United States. Its technology-enabled solutions are delivered primarily through company-hosted software, or software as a service supported by sales, account management, implementation services, and consulting. The company operates through two segments, Revenue Cycle Management and Spend Management. The Revenue Cycle Management segment provides a suite of products and services spanning the hospital revenue cycle workflow, including patient access and financial responsibility, charge capture and integrity, pricing analysis, claims processing and denials management, payor contract management, revenue recovery, and accounts receivable services. The Spend Management segment offers a suite of technology-enabled services that help its customers to manage their non-labor expense categories. This segment also offers a range of services, including group purchasing; performance improvement consulting services, such as implantable physician preference items; cost and utilization management and service line consulting; and business intelligence tools. As of December 31, 2009, the company served approximately 125 health systems; 3,300 acute care hospitals; and 40,000 ancillary or non-acute provider locations. MedAssets, Inc. has a strategic relationship with Foodbuy LLC. The company was incorporated in 1999 and is headquartered in Alpharetta, Georgia.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net